Ads
related to: novavax vaccine
Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 17 hours agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 12 hours agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 2 days agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 2 days agoGaithersburg’s Novavax Inc. (NASDAQ: NVAX) says it will have an updated Covid-19 vaccine ready in...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 22 hours agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September - ...
Benzinga· 2 days agoWhat Happened: The Maryland-based biotechnology company’s shares were trading higher by 21.60% to...
What's Going On With Novavax Stock Thursday? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoWhat To Know: The FDA’s committee of independent advisors voted unanimously on Wednesday to...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 2 days agoKP.2 now accounts for 28.5% of known cases, compared to 8% of JN.1, CDC data shows. Since the two strains are part of the same Omicron family, the ...
Novavax Shares Jump on Planned Covid Vaccine Delivery
Market Watch· 2 days agoShares of Novavax climbed Thursday after the company said it would be able to deliver a regulator-recommended vaccine against a strain of Covid-19 by September ...